PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 1727516

Serum-plasma differences in total cholesterol: what correction factor should be used?

G G Wickus·R O Dukerschein
View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Blood Specimen CollectionCholesterolEdetic AcidHumansMiddle AgedCommentLetter

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

G G Wickus, R O Dukerschein. 1992-01-08. Serum-plasma differences in total cholesterol: what correction factor should be used?. https://doi.org/10.1001/jama.1992.03480020044024

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Therapeutic drug monitoring of tacrolimus with the dried blood spot method.

In a preliminary investigation an assay for tacrolimus based on fingerprick sampling and consecutive application as a blood spot on sampling paper has been developed. The dried blood spot was analysed by HPLC-tandem mass spectrometry. The validated range was 1-30 microg/l. Intra- and inter-assay variability for precision and accuracy was <7.5% and 15%, respectively. Tacrolimus concentrations of 24 stable out patients were compared after both blood spot sampling and conventional venous sampling. Method agreement was investigated with the methods of Passing and Bablok and Bland Altman and proved suitable for clinical use. The dried blood spot method for tacrolimus seems promising for patient monitoring.

Blood Specimen Collection↗